Intracranial Aneurysm Market to Reach USD 5.4 Billion by 2034, Growing from USD 2.5 Billion in 2025 - SRI

London, UK - August 2026 | Strategic Revenue Insights Inc. - Public health campaigns aimed at raising awareness of aneurysm symptoms are starting to shift diagnosis earlier, and that earlier detection is reshaping demand across the intracranial aneurysm treatment landscape. The global intracranial aneurysm market is valued at USD 2.5 billion in 2025 and is projected to reach USD 5.4 billion by 2034, expanding at a CAGR of 9.00% during the forecast period, according to Strategic Revenue Insights Inc. The findings draw on primary interviews with neurosurgeons, interventional neuroradiologists, and neurovascular center administrators, combined with secondary research across Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa, led by lead analyst Thomas Müller.

Key Takeaways

• The intracranial aneurysm market is valued at USD 2.5 billion in 2025 and is forecast to reach USD 5.4 billion by 2034, a CAGR of 9.00%.
• Endovascular Coiling is the largest treatment segment, while Flow Diverter Stents are the fastest-growing as they gain favor for treating complex aneurysms.
• Product diversification and the integration of AI and machine learning are enhancing the precision of aneurysm diagnosis and treatment.
• North America leads the market on advanced healthcare infrastructure and disease prevalence, while Asia Pacific is the fastest-growing region amid rising healthcare expenditure.
• Medtronic, Stryker, and Johnson & Johnson (Cerenovus) are among the leading competitors.

Full report access: https://www.strategicrevenueinsights.com/industry/intracranial-aneurysm-market

Earlier Diagnosis and a Shift Toward Minimally Invasive Repair

The market's growth is rooted in a genuine awareness shift: public health campaigns and educational programs are raising understanding of aneurysm symptoms and risks among both healthcare professionals and patients, leading to earlier diagnosis and intervention. That trend is reinforced by government initiatives focused on improving neurological health and reducing the burden of cerebrovascular disease, alongside advances in imaging techniques and the growing availability of specialized treatment centers that support accurate diagnosis.

Clinical preference is moving decisively toward minimally invasive procedures such as endovascular coiling and flow diverter stents, which offer reduced recovery times and lower complication rates than traditional surgery. That shift is driving companies to invest in research and development to improve the efficacy and safety of these techniques, while also expanding product portfolios to include a broader range of embolization coils, flow diversion devices, and microcatheters that address diverse patient needs.

Technology and geography are the two forces shaping where growth concentrates next. The integration of artificial intelligence and machine learning is improving the precision of aneurysm diagnosis and treatment, while Asia Pacific is emerging as a key growth region as cerebrovascular disease prevalence, healthcare expenditure, and healthcare infrastructure all improve in countries such as China and India, prompting companies to expand through local partnerships.

Market Segmentation

By Treatment Type: Endovascular Coiling is the most widely used treatment given its minimally invasive nature and effectiveness in preventing aneurysm rupture, while Flow Diverter Stents are gaining popularity, particularly for complex aneurysms not suitable for coiling. Intrasaccular Flow Disruptors and Surgical Clipping remain available options, and Balloon & Stent-Assisted Coiling and Liquid Embolics serve specific cases such as wide-neck and ruptured aneurysms.

By Product: Embolization Coils are the most commonly used product given their effectiveness in promoting clotting and reducing rupture risk, while Flow Diversion Devices offer a minimally invasive option for complex aneurysms. Stents & Balloons provide additional support for wide-neck aneurysms, Microcatheters & Guidewires are essential delivery tools, and Surgical Clips remain in use for traditional clipping procedures.

By Aneurysm Type: Saccular Aneurysm is the most common type, typically treated with endovascular coiling or surgical clipping, while Fusiform Aneurysm often requires more complex approaches such as flow diversion or stenting. Ruptured Aneurysm requires immediate intervention, Unruptured Aneurysm may be monitored or treated with minimally invasive procedures, and Wide-Neck Aneurysm often requires stents or balloons for added support.

By End Use: Hospitals & Neurovascular Centers are the primary end users, offering the facilities and specialized teams needed for complex procedures and comprehensive care. Neurosurgery Departments play a critical role for patients requiring surgical intervention, supported by advanced imaging and surgical equipment, while Ambulatory Surgical Centers offer a convenient, cost-effective option for minimally invasive procedures and follow-up care.

Regional Outlook

North America is the leading regional market, underpinned by advanced healthcare infrastructure and high prevalence of cerebrovascular diseases, while Asia Pacific is experiencing rapid growth driven by increasing healthcare expenditure and improving infrastructure. Europe's device manufacturers continue to operate under a staggered conformity assessment timeline for medical devices, with higher-risk implantable devices given until the end of 2027 and medium- and lower-risk devices until the end of 2028 to complete certification, keeping compliance and clinical-evidence spending elevated across the region without a fixed sell-off deadline on already-compliant products. Latin America and the Middle East & Africa round out the report's regional coverage as healthcare infrastructure and disease awareness continue to develop across those markets.

Competitive Landscape

Medtronic offers a range of innovative endovascular devices designed to improve patient outcomes and reduce recovery times, backed by a strong research and development focus that has helped it maintain a competitive edge. Stryker emphasizes product innovation and customer satisfaction across a wide range of devices, including flow diverter stents and embolization coils, supported by a global presence serving a diverse customer base. Johnson & Johnson (Cerenovus) is known for advanced medical devices addressing cerebrovascular disease, with a focus on innovation and patient-centric solutions strengthened by strategic partnerships with healthcare providers.

Market Restraints

The stringent regulatory environment imposes rigorous standards and guidelines for medical device development and approval, requiring companies to navigate complex processes and invest in compliance measures that can increase costs and delay product launches. Intense competition among numerous companies vying for market share also creates pricing pressure and margin risk, particularly for smaller companies with limited resources, alongside the risk of product recalls and litigation tied to device malfunctions or adverse events.

Related Reports

https://www.strategicrevenueinsights.com/industry/asthma-and-copd-drugs-market

https://www.strategicrevenueinsights.com/industry/at-home-drug-of-abuse-testing-market

https://www.strategicrevenueinsights.com/industry/atherosclerosis-drugs-market

https://www.strategicrevenueinsights.com/industry/at-home-peptic-ulcer-testing-market

https://www.strategicrevenueinsights.com/industry/atp-assay-market

Frequently Asked Questions

What is the intracranial aneurysm market size in 2025?

The global intracranial aneurysm market was valued at USD 2.5 billion in 2025 and is projected to reach USD 5.4 billion by 2034, growing at a CAGR of 9.00%.

What is driving growth in the intracranial aneurysm market?

Growth is driven by the increasing prevalence of cerebrovascular diseases, advancements in medical technology such as minimally invasive procedures and imaging techniques, and growing awareness leading to earlier diagnosis.

Which region leads the intracranial aneurysm market?

North America leads the market due to advanced healthcare infrastructure and high prevalence of cerebrovascular diseases, while Asia Pacific is the fastest-growing region amid rising healthcare expenditure and improving infrastructure.

Who are the top companies in the intracranial aneurysm market?

Leading companies include Medtronic, Stryker, and Johnson & Johnson (Cerenovus).

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases